Evidence map›Paper›PMID 40399317›Full record

ArticleScientific reports2025

Exploration of 1-(2,4-difluorophenyl)-5-oxopyrrolidine-3-carboxylic acid derivatives effect on triple-negative breast, prostate cancer and melanoma cell 2D and 3D cultures.

Guoda Pranaitytė, Birutė Grybaitė, Ugne Endriulaityte, Vytautas Mickevičius, Vilma Petrikaitė

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guoda PranaitytėKaunas University of Technology, Radvilėnų Rd. 19, Kaunas, LT-50254, Lithuania.
Birutė GrybaitėKaunas University of Technology, Radvilėnų Rd. 19, Kaunas, LT-50254, Lithuania.
Ugne EndriulaityteLaboratory of Drug Targets Histopathology, Institute of Cardiology, Lithuanian University of Health Sciences, Sukileliu pr. 13, Kaunas, LT-50162, Lithuania.
Vytautas MickevičiusKaunas University of Technology, Radvilėnų Rd. 19, Kaunas, LT-50254, Lithuania. vytautas.mickevicius@ktu.lt.
Vilma PetrikaitėLaboratory of Drug Targets Histopathology, Institute of Cardiology, Lithuanian University of Health Sciences, Sukileliu pr. 13, Kaunas, LT-50162, Lithuania. vilma.petrikaite@lsmuni.lt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

1-Substituted 5-oxopyrrolidine-3-carboxylic acid and its derivatives play an important role as components of many biologically active molecules. This study describes the synthesis of 1-(2,4-difluorophenyl)-5-oxopyrrolidine-3-carboxylic acid derivatives and their anticancer properties. The target compounds were prepared using 2,4-difluoroniline as a starting material; in this way, derivatives of benzimidazoles, hydrazones and azoles were formed. Investigation of the anticancer activity of all synthesized compounds showed that the hydrazones had the strongest effect on cancer cell lines. Compounds were tested for their cytotoxic effect by the MTT assay in human triple-negative breast cancer MDA-MB-231, prostate adenocarcinoma PPC1, melanoma A375 and human foreskin fibroblasts CRL-4001 after 72 hours of incubation. The impact of the compounds on cancer cell migration was assessed using a 'wound healing assay'. Activity in 3D cultures was determined by evaluating changes in spheroid size and assessing cell viability. Overall, the selected compounds 7b, 9c, 9e, 9f and 10 exhibited greater activity in the A375 cell line and were less active against the MDA-MB-231 cell line. Compounds 9c, 9e and 10 showed relatively higher selectivity for cancer cells over fibroblasts. Hydrazone 9f, bearing N'-(4-methylbenzylidene) moiety, was identifiedasthe most cytotoxic compound in both prostate adenocarcinoma PPC-1 and melanoma A375 cells in monolayer and 3D culture models. Compound 9e, with N'-(4-bromobenzylidene) moiety, exhibited the most pronounced inhibitory effect on cell migration as determined by the 'wound healing' assay.

Indexed as

Antineoplastic AgentsMelanomaProstatic NeoplasmsTriple Negative Breast NeoplasmsCell Culture TechniquesCell Line, TumorCell MovementCell ProliferationCell SurvivalDrug Screening Assays, AntitumorFemaleHumansMaleAntineoplastic AgentsAzolesCell migrationCytotoxicityHydrazonesMelanomaProstate carcinomaTriple-negative breast cancerTumor spheroids

Identifiers

PMID40399317
PMCPMC12095558

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.